This study aims to assess the potential of the use of phosphorus and calcium as biomarkers in the clinical evaluation of patients with acromegaly and clarify their relationship with SAGIT and other common biomarkers (GH, IGF-1) in larger population sizes. This evidence concerns the gene IGF1 and acromegaly.